as on February 5, 2026 at 2:29 am IST
Day's Low
Day's High
2.08%
Downside
4.77%
Upside
52 Week's Low
52 Week's High
65.11%
Downside
37.14%
Upside
Check Dyne Therapeutics, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.0B
EPS (TTM)
-3.531
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0.19
EBITDA
-447.2M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-60.66%
Compare market cap, revenue, PE, and other key metrics of Dyne Therapeutics, Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.0B | -8.63% | NA | 0.00% | |
| BUY | $122.3B | 117.87% | 33.56 | 31.35% | |
| BUY | $47.7B | 122.79% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.19% | 18.28 | 32.13% |
The Dyne Therapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Dyne Therapeutics, Inc investment value today
Current value as on today
₹1,27,132
Returns
₹27,132
(+27.13%)
Returns from Dyne Therapeutics, Inc Stock
₹23,259 (+23.26%)
Dollar Returns*
₹3,873 (+3.87%)
Based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Dyne Therapeutics, Inc. Average target price of $39.12
Get share price movements and forecasts by analysts on Dyne Therapeutics, Inc.
What analysts predicted
53.4%UPSIDE
Target Price
$39.12
Current Price
$18.23
Analyzed by
13 Analysts
Target
$39.12
Dyne Therapeutics, Inc target price $39.12, a slight upside of 53.4% compared to current price of $18.23. According to 13 analysts rating.
Search interest for Dyne Therapeutics, Inc Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 09 December
Tue, 04:30 PM
-Dyne Therapeutics announces $300 million public offering, raising concerns about shareholder dilution despite positive DMD trial results.
Wed, 03:04 AM
-Dyne Therapeutics falls 17% after announcing secondary stock offering, reversing gains from positive DMD treatment trial results.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, DYN stock has moved up by 7.1%
Best in 3 Years
![]()
In the last 3 years, DYN has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 55.4% return, outperforming this stock by 27.2%
| Organisation | Dyne Therapeutics, Inc |
| Headquarters | 1560 Trapelo Road, Waltham, MA, United States, 02451 |
| Industry | Commercial Services |
| CEO | Mr. John G. Cox M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Lucia Celona | Chief Human Resource Officer |
Dr. Oxana Beskrovnaya Ph.D. | Chief Innovation Officer |
Dr. Axel Wiest | Senior VP and Head of Portfolio Strategy & Operations |
Mr. James P. Bilotta M.B.A. | Chief Digital & Information Officer |
Mr. Daniel Wilson | Senior VP & Head of Legal |
Dr. Rajesh Manchanda Ph.D. | Chief Technical Officer |
Mr. John G. Cox M.B.A. | CEO, President & Director |
Ms. Johanna Friedl-Naderer | Chief Commercial Officer |
Dr. Douglas Kerr M.B.A., M.D., Ph.D. | Chief Medical Officer |
Mr. Erick J. Lucera C.F.A., CPA | CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer |
Dyne Therapeutics, Inc share price today is $18.23 as on at the close of the market. Dyne Therapeutics, Inc share today touched a day high of $19.1 and a low of $17.85.
Dyne Therapeutics, Inc share touched a 52 week high of $25 on and a 52 week low of $6.36 on . Dyne Therapeutics, Inc stock price today i.e. is closed at $18.23,which is 27.08% down from its 52 week high and 186.64% up from its 52 week low.
Dyne Therapeutics, Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Dyne Therapeutics, Inc (DYN) shares with as little as ₹90.453 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹904.53 in Dyne Therapeutics, Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Dyne Therapeutics, Inc share’s latest price of $18.23 as on February 5, 2026 at 2:29 am IST, you will get 0.5485 shares of Dyne Therapeutics, Inc. Learn more about
fractional shares .
Dyne Therapeutics, Inc stock has given -8.63% share price returns and 25.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?